BSE Live
Dec 12, 16:01Prev. Close
1592.45
Open Price
1577.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 12, 15:59Prev. Close
1590.60
Open Price
1590.80
Bid Price (Qty.)
1572.20 (67)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Eris Lifesciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 488.87 | 431.24 | 404.64 | 442.20 | 394.50 | |
| Net CashFlow From Operating Activities | 1,065.01 | 486.01 | 291.74 | 378.26 | 375.36 | |
| Net Cash Used In Investing Activities | -79.97 | -1,854.52 | -982.10 | -319.61 | -323.36 | |
| Net Cash Used From Financing Activities | -881.32 | 1,379.78 | 688.03 | -44.70 | -82.40 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 1.77 | 0.00 | 7.49 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 105.49 | 11.26 | 5.15 | 13.96 | -30.39 | |
| Cash And Cash Equivalents Begin of Year | 94.25 | 82.98 | 50.87 | 36.92 | 67.31 | |
| Cash And Cash Equivalents End Of Year | 199.74 | 94.25 | 56.02 | 50.87 | 36.92 |
27.11.2025
Eris Life Standalone September 2025 Net Sales at Rs 650.50 crore, up 51.72% Y-o-Y
19.11.2025
Eris Life Consolidated September 2025 Net Sales at Rs 792.41 crore, up 7.23% Y-o-Y
12.11.2025
Eris Lifesciences net profit jumps 39 percent YoY to Rs 134 crore
12.08.2025
Eris Life Consolidated June 2025 Net Sales at Rs 773.00 crore, up 7.4% Y-o-Y
17.01.2023
Eris Lifesciences Q3 PAT seen up 7.2% YoY to Rs 1,080 cr: Nirmal Bang
08.07.2022
Eris Lifesciences Q1 PAT seen up 4.3% YoY to Rs 111.3 cr: Prabhudas Lilladher
14.04.2022
Eris Lifesciences Q4 PAT seen up 30.7% YoY to Rs 89.2 cr: Prabhudas Lilladher
13.01.2022
Eris Lifesciences Q3 PAT seen up 12.4% YoY to Rs 101.4 cr: Prabhudas Lilladher